Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2

Biochem Biophys Res Commun. 2009 Jan 23;378(4):857-61. doi: 10.1016/j.bbrc.2008.12.001. Epub 2008 Dec 9.

Abstract

We have previously reported that morphine induces apoptosis. However, the underlying molecular mechanisms remain to be elucidated. Toll-like receptor 2 (TLR2), a key immune receptor in the TLR family, modulates cell survival and cell death in various systems. Evidence indicates that beta-arrestin 2 acts as a negative regulator of innate immune activation by TLRs. Here, we investigated the roles of TLR2, the downstreaming mediator MyD88, and beta-arrestin 2 in morphine-induced apoptosis. We showed that overexpression of TLR2 in HEK293 cells caused a significant increase in apoptosis after morphine treatment. Inhibition of MyD88 by transfecting dominant negative MyD88 or overexpression of beta-arrestin 2 by transfecting beta-arrestin 2 full length plasmid in TLR2 overexpressing HEK293 cells attenuated morphine-induced apoptosis. Our study thus demonstrates that TLR2 signaling mediates the morphine-induced apoptosis, and beta-arrestin 2 is a negative regulator in morphine-induced, TLR2-mediated apoptosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis* / drug effects
  • Arrestins / antagonists & inhibitors
  • Arrestins / biosynthesis*
  • Cell Line
  • Humans
  • Immunity, Innate
  • Morphine / pharmacology*
  • Myeloid Differentiation Factor 88 / antagonists & inhibitors
  • Toll-Like Receptor 2 / agonists
  • Toll-Like Receptor 2 / antagonists & inhibitors
  • Toll-Like Receptor 2 / physiology*
  • beta-Arrestin 2
  • beta-Arrestins

Substances

  • ARRB2 protein, human
  • Arrestins
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • Toll-Like Receptor 2
  • beta-Arrestin 2
  • beta-Arrestins
  • Morphine